Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma

Inna Chen^*, Victoria M. Raymond, Jennifer A. Geis, Eric A. Collisson, Benny V. Jensen, Kirstine L. Hermann, Mark G. Erlander, Margaret Tempero, Julia S. Johansen

^*Corresponding author af dette arbejde